|
Reference #:
2000-090
Inventors/Contributors
Elliott Richelson, M.D.
Description
Mayo Clinic researchers and their collaborators have developed novel small molecule compounds that selectively inhibit norepinephrine, serotinin and dopamine reuptake.
Patent Status
|
|
Contact
Nathan L. Stacy, Licensing Manager
stacy.nathan@mayo.edu
|
|
Mayo Foundation for Medical Education and Research
Office of Technology Commercialization
Centerplace 4
200 First Street SW
Rochester, MN 55905
|
Phone: (507) 538-1652
Fax: (507) 284-5410
|
|
|
